receptors

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela V Maus, Sara Alexander, Michael R Bishop, Jennifer N Brudno, Colleen Callahan, Marco L Davila, Claudia Diamonte, Jorg Dietrich, Julie C Fitzgerald, Matthew J Frigault, Terry J Fry, Jennifer L Holter-Chakrabarty, Krishna V Komanduri, Daniel W Lee, Frederick L Locke, Shannon L Maude, Philip L McCarthy, Elena Mead, Sattva S Neelapu, Tomas G Neilan, Bianca D Santomasso, Elizabeth J Shpall, David T Teachey, Cameron J Turtle, Tom Whitehead, Stephan A Grupp

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001511; DOI: 10.1136/jitc-2020-001511
Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors
Isobel Okoye, Lai Xu, Melika Motamedi, Pallavi Parashar, John W Walker, Shokrollah Elahi

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001849; DOI: 10.1136/jitc-2020-001849
Role of immunotherapy in Ewing sarcoma
Erin Morales, Michael Olson, Fiorella Iglesias, Saurabh Dahiya, Tim Luetkens, Djordje Atanackovic

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e000653; DOI: 10.1136/jitc-2020-000653
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
George Mo, Hao-Wei Wang, Aimee C Talleur, Shilpa A Shahani, Bonnie Yates, Haneen Shalabi, Michael G Douvas, Katherine R Calvo, Jack F Shern, Sridhar Chaganti, Katharine Patrick, Young Song, Terry J Fry, Xiaolin Wu, Brandon M Triplett, Javed Khan, Rebecca A Gardner, Nirali N Shah

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001563; DOI: 10.1136/jitc-2020-001563
Interleukin-15 and cancer: some solved and many unsolved questions
Piera Filomena Fiore, Sabina Di Matteo, Nicola Tumino, Francesca Romana Mariotti, Gabriella Pietra, Selene Ottonello, Simone Negrini, Barbara Bottazzi, Lorenzo Moretta, Erwan Mortier, Bruno Azzarone

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001428; DOI: 10.1136/jitc-2020-001428
Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells
Gagan Bajwa, Inès Lanz, Mara Cardenas, Malcolm K Brenner, Caroline Arber

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001487; DOI: 10.1136/jitc-2020-001487
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, Deborah Sandfort, Julia Lahrberg, Stephan Klöß, Christina Kloth, Caroline Mangare, Agnes Bonifacius, Sabine Tischer-Zimmermann, Rainer Blasczyk, Britta Maecker-Kolhoff, Barbara Uchanska-Ziegler, Hinrich Abken, Axel Schambach, Michael Hudecek, Britta Eiz-Vesper

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000736; DOI: 10.1136/jitc-2020-000736
Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor
Boning Zhang, John Victor Napoleon, Xin Liu, Qian Luo, Madduri Srinivasarao, Philip S Low

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000756; DOI: 10.1136/jitc-2020-000756
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, John Barrett, Renier J Brentjens, Jill Brufsky, Jorge Cortes, Marcos De Lima, Stephen J Forman, Ephraim J Fuchs, Linda J Fukas, Steven D Gore, Mark R Litzow, Jeffrey S Miller, John M Pagel, Edmund K Waller, Martin S Tallman

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000810; DOI: 10.1136/jitc-2020-000810
T-cell agonists in cancer immunotherapy
Yeonjoo Choi, Yaoyao Shi, Cara L Haymaker, Aung Naing, Gennaro Ciliberto, Joud Hajjar

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000966; DOI: 10.1136/jitc-2020-000966

Main menu

receptors

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

receptors

Pages